Park Medi World Limited is a prominent healthcare provider in North India, distinguished by its position as the largest private hospital chain in Haryana and the second largest in the region by bed capacity. The company operates a network of 14 NABH-accredited multi-super specialty hospitals, with a significant number also holding NABL accreditation. As of December 2025, its infrastructure includes 3,250 beds, of which 870 are dedicated ICU beds. The company's core mission is to deliver high-quality and affordable medical services, encapsulated in its vision of "wellness for all." It offers a broad spectrum of services across more than 30 super-specialties, supported by a robust team of over 1,014 doctors and 2,142 nurses.

Founded in 2005 by Dr. Ajit Gupta, the company has grown through a dual strategy of organic expansion and strategic acquisitions. This "cluster-based approach" focuses on establishing a dense network of hospitals in close proximity, primarily in Haryana, Delhi, Punjab, and Rajasthan, to leverage brand recognition, optimize resource allocation, and achieve economies of scale. The leadership is a key asset, with a doctor-led professional management team. The promoters, Dr. Ajit Gupta and Dr. Ankit Gupta, bring extensive experience in the medical profession and hospital administration, which has been instrumental in building the company's brand equity and operational success. This blend of medical expertise and business acumen underpins the company's strategy of acquiring, integrating, and turning around hospitals to drive growth and profitability.

Official Website: https://www.parkhospital.in/

• Q3 FY26 Performance:

• Revenue from Operations: Grew by 17.76% year-over-year (YoY) to Rs. 4,100 million from Rs. 3,481 million in Q3 FY25.

• EBITDA: Increased by 20.05% YoY to Rs. 994 million. The EBITDA margin saw a slight expansion to 24.25% from 23.79% in the prior year's quarter.

• Profit After Tax (PAT): Rose by 15.78% YoY to Rs. 528 million. The PAT margin remained stable at 12.89% compared to 13.11% in Q3 FY25.

• Earnings Per Share (EPS): Basic EPS for the quarter stood at Rs. 1.35, up from Rs. 1.19 in Q3 FY25.

• 9M FY26 Performance:

• Revenue from Operations: Recorded a 17.25% YoY increase to Rs. 12,189 million from Rs. 10,397 million in 9M FY25.

• EBITDA: Grew by 12.17% YoY to Rs. 3,170 million. However, the EBITDA margin contracted to 26.00% from 27.18% in the same period last year, reflecting the costs associated with integrating new acquisitions.

• Profit After Tax (PAT): Showed significant growth of 42.60% YoY, reaching Rs. 1,968 million compared to Rs. 1,380 million in 9M FY25. The PAT margin expanded notably to 16.14% from 13.27%.

• Earnings Per Share (EPS): Basic EPS for the nine-month period was Rs. 5.09, a substantial increase from Rs. 3.59 in 9M FY25.

• Expense Analysis (9M FY26):

• Total expenses amounted to Rs. 9,020 million. Key components include Employee benefit expenses (Rs. 2,372 million), Other Expenses (Rs. 2,631 million), and Cost of materials/services (Rs. 2,166 million).

• Finance costs decreased significantly to Rs. 449 million from Rs. 703 million in 9M FY25, indicating improved balance sheet management post-IPO.

The company has delivered strong top-line growth and a substantial increase in net profitability for the nine-month period, driven by stable patient volumes and an improved case mix.

• Affordable and High-Quality Care Model: The company strategically targets the lower-middle and middle-class patient segments, a large and underserved demographic. Its vision is to provide high-quality care at accessible price points, which is supported by the fact that approximately 84% of its revenue is derived from government schemes and Public Sector Undertakings (PSUs).

• Cluster-Based Expansion Strategy: Park Medi World focuses on building a high density of hospitals within specific geographic clusters in North India. This approach enhances brand recognition, allows for efficient sharing of clinical and managerial resources, improves supply chain economics, and creates a strong competitive moat in its core markets.

• Proven Acquisition and Integration Expertise: The company has a demonstrated track record of successfully acquiring and integrating hospitals into its network. Acquired assets contribute significantly, accounting for 55% of beds, 50% of revenue, and 58% of PAT in FY25. This inorganic growth engine is a core component of its expansion strategy.

• Doctor-Led Professional Management: The company is led by its promoters, who are experienced medical doctors. This provides deep domain expertise in clinical operations and healthcare management, fostering a culture that prioritizes patient care while maintaining financial discipline.

The company's unique value proposition is its ability to deliver affordable healthcare at scale through a disciplined, cluster-focused acquisition and integration model, overseen by a management team with deep medical expertise.

• Market Growth Projections: The Indian healthcare delivery market is projected to grow at a Compound Annual Growth Rate (CAGR) of 10-12% between FY24 and FY29, expanding from Rs. 6.3 trillion to Rs. 10.2-10.8 trillion. The In-Patient Department (IPD) segment is expected to be the primary driver of this growth.

• Regional Focus on North India: North India's healthcare market is anticipated to grow at the fastest pace among all regions. Several states where Park Medi World has a presence, such as Uttar Pradesh (12.5 beds per 10,000 population), Rajasthan (14.0), and Haryana (14.0), have bed densities below the National Health Policy (NHP) recommendation of 20 beds, indicating a significant supply-demand gap.

• Structural Growth Drivers:

• Rising Health Insurance Penetration: Health insurance coverage is expected to increase from 40-42% in FY24 to 45-50% by FY26, improving access and affordability for hospitalization.

• Increasing Prevalence of Non-Communicable Diseases (NCDs): The burden of NCDs like cardiovascular diseases and cancer is rising, driving demand for specialized and long-term care.

• Growing Medical Tourism: India is becoming a key destination for medical tourists, with the number of arrivals growing at a CAGR of 20% between 2009 and 2024 (excluding the COVID-19 impact).

• Government Focus: The government's healthcare budget has grown at a 12% CAGR (FY16-FY25), and initiatives like the Ayushman Bharat scheme are expanding healthcare coverage to millions of families.

The healthcare industry is poised for sustained growth, with North India presenting a particularly attractive market due to favorable demographics, supply gaps, and supportive government policies.

• Network Expansion (Inorganic): The company actively pursues acquisitions to expand its footprint. Recent examples include the acquisition of the 200-bed Febris Multi-Speciality Hospital in New Delhi and the 360-bed KP Institute of Medical Sciences in Agra for approximately Rs. 245 crore. These acquisitions align with the cluster strategy, strengthening presence in Delhi and Uttar Pradesh.

• Network Expansion (Organic): Park Medi World is also expanding organically with several projects in the pipeline. This includes the construction of new hospitals in Panchkula (300 beds) and Rohtak (250 beds), increasing capacity at its Ambala hospital (to 450 beds), and operating a 400-bed hospital in Gorakhpur under an O&M agreement.

• Scaling Operations and Efficiency: The company is focused on improving operational efficiencies at existing and newly acquired facilities. This involves driving higher occupancy, optimizing the specialty mix towards higher-margin procedures, and leveraging technology like the iMARS advanced robotics system for minimally invasive surgeries to reduce patient recovery times.

• Diversification of Payor Mix: A dedicated team has been established to attract more cash-paying and insurance-paying patients, including a focus on international patients through a new marketing department. This aims to diversify revenue streams beyond government schemes.

The company's growth is driven by a balanced strategy of aggressive, cluster-focused inorganic expansion, targeted organic projects, and a continuous focus on enhancing operational efficiencies.

• Bed Capacity Growth: The company has steadily increased its bed capacity from 3,000 in 9M FY25 to 3,250 as of Q3 FY26. This reflects the addition of new hospitals to its network.

• Occupancy Ratio: The occupancy ratio has shown a positive trend, increasing from 62% in 9M FY25 to 65% in Q3 FY26. This indicates improving utilization of its available bed capacity.

• Planned Capex and Expansion Pipeline: The company has a clear roadmap to reach 5,260 beds by March 2028. A significant portion of this expansion (~88%) is planned for Tier 2 and Tier 3 cities.

• Haryana: Planned capacity of 2,350 beds.

• Uttar Pradesh: Planned capacity of 700 beds.

• Punjab: Planned capacity of 900 beds.

• Rajasthan: Planned capacity of 550 beds.

• Delhi: Planned capacity of 400 beds.

• Average Revenue Per Occupied Bed (ARPOB): ARPOB has seen a consistent increase, rising from Rs. 25,527 in 9M FY25 to Rs. 27,482 in Q3 FY26, reflecting an improved case mix and better realization per patient.

The company is effectively managing its capacity utilization while executing a well-defined, capital-intensive expansion plan focused on strengthening its presence in North India.

• Continued Network Expansion in North India: The primary focus is to continue expanding the hospital network in existing and adjacent states, leveraging the cluster-based model. The goal is to establish a presence in state capitals or district headquarters to capture high-potential urban catchments.

• Deepen Specialization and Technology Adoption: The company plans to enhance its service offerings by investing in advanced medical equipment and introducing more super-specialties. It has already deployed iMARS robotic surgery systems in three hospitals and has approval for kidney transplants in five hospitals, with plans to expand such advanced services.

• Integration of Acquired Assets: An immediate priority is the seamless integration of recently acquired hospitals like Febris and KPIMS. The objective is to improve their asset utilization, strengthen clinical offerings, and drive operational efficiencies to bring their performance in line with the rest of the network.

• Talent Management and Development: The company aims to retain and attract skilled doctors and clinicians by providing continuous training, organizing workshops on medical advancements, and offering access to global best practices and advanced medical devices.

The future strategy is centered on disciplined expansion within North India, enhancing clinical capabilities through technology, and ensuring efficient integration of new assets to drive sustainable profitability.

• Quarterly Margin Performance (Q3 FY26):

• EBITDA Margin: Stood at 24.25%, a slight improvement of 46 basis points from 23.79% in Q3 FY25.

• PAT Margin: Was 12.89%, showing a minor contraction from 13.11% in Q3 FY25.

• Nine-Month Margin Performance (9M FY26):

• EBITDA Margin: Contracted to 26.00% from 27.18% in 9M FY25.

• PAT Margin: Expanded significantly to 16.14% from 13.27% in 9M FY25, aided by lower finance costs.

• Management Commentary on Margins: The management has indicated that margins have remained broadly stable but reflect the ongoing integration and initial gestation period of recently acquired hospitals. This is in line with expectations, as new facilities typically take 12 to 24 months to ramp up and reach optimal profitability.

While quarterly margins show stability, the nine-month EBITDA margin reflects the short-term impact of integrating new hospitals, a factor that is expected to normalize as these assets mature.

• Bed Capacity Leadership: In North India, Park Medi World is the second-largest private hospital chain with 3,250 beds, behind Max Healthcare (4,598 beds) but ahead of competitors like Fortis (2,944 beds), Medanta (2,390 beds), and Kailash Healthcare (2,250+ beds).

• Operational Benchmarking (H1FY26):

• Occupancy Rate: At 68%, Park Medi World's occupancy is competitive and higher than several peers, including Fortis (62%), Global Health (63%), and Narayana (53%). It is slightly below Max Healthcare (76%).

• Average Length of Stay (ALOS): The company's ALOS is 6.4 days. This is higher than most of its listed peers, such as Max (4.0 days), Fortis (3.8 days), Global Health (4.3 days), and KIMS (3.6 days), which may indicate a different case mix or opportunities for efficiency improvements.

Park Medi World holds a strong competitive position in North India based on its scale and high occupancy rates, although its average length of stay is longer than that of its key peers.

• Integration Risk: The company's growth strategy is heavily dependent on acquisitions. The process of integrating new hospitals, standardizing operations, and aligning cultures carries execution risks that could temporarily impact profitability and operational efficiency, as noted by the management regarding current margins.

• Geographic Concentration: The business is concentrated in North India. Any adverse economic, regulatory, or social conditions specific to this region could have a disproportionate impact on the company's performance.

• Dependence on Government Schemes: With approximately 84% of revenue coming from government schemes and PSUs, the company is exposed to risks related to policy changes, delays in payments, or revisions in tariff rates, which could affect revenue and cash flows.

• Competition for Talent: The healthcare industry faces intense competition for skilled doctors, nurses, and medical professionals. The ability to attract and retain top talent is critical for maintaining quality of care and is a persistent operational challenge.

The company's aggressive acquisition strategy, geographic focus, and high dependence on government payors are key risks that require careful management.

• Acquisition of Febris Multi-Speciality Hospital: The company acquired this 200-bed hospital in Narela, New Delhi, through its wholly-owned subsidiary via the Insolvency and Bankruptcy Code (IBC) process. This strategic addition enhances its presence in a densely populated catchment with access to Delhi, Haryana, and Western Uttar Pradesh.

• Acquisition of KP Institute of Medical Sciences (KPIMS): Park Medi World acquired a 100% stake in this 360-bed, NABH-accredited hospital in Agra for approximately Rs. 245 crore in an all-cash deal. This move strengthens the company's footprint in Uttar Pradesh under its cluster strategy and is expected to add immediate value post-integration.

These recent acquisitions underscore the company's commitment to its inorganic growth strategy, expanding its bed capacity and strengthening its market position in key North Indian territories.